Please use this identifier to cite or link to this item: https://doi.org/10.1038/s41598-021-83601-6
Title: Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment
Authors: Chai, Yuek Ling 
Chong, Joyce R 
Raquib, Ainiah R 
Xu, Xin 
Hilal, Saima 
Venketasubramanian, Narayanaswamy
Tan, Boon Yeow 
Kumar, Alan P 
Sethi, Gautam 
Chen, Christopher P 
Lai, Mitchell KP 
Keywords: Science & Technology
Multidisciplinary Sciences
Science & Technology - Other Topics
Issue Date: 17-Feb-2021
Publisher: NATURE RESEARCH
Citation: Chai, Yuek Ling, Chong, Joyce R, Raquib, Ainiah R, Xu, Xin, Hilal, Saima, Venketasubramanian, Narayanaswamy, Tan, Boon Yeow, Kumar, Alan P, Sethi, Gautam, Chen, Christopher P, Lai, Mitchell KP (2021-02-17). Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment. SCIENTIFIC REPORTS 11 (1). ScholarBank@NUS Repository. https://doi.org/10.1038/s41598-021-83601-6
Abstract: Cerebrovascular disease (CeVD) and neurodegenerative dementia such as Alzheimer’s disease (AD) are frequently associated comorbidities in the elderly, sharing common risk factors and pathophysiological mechanisms including neuroinflammation. Osteopontin (OPN) is an inflammatory marker found upregulated in vascular diseases as well as in AD. However, its involvement in vascular dementia (VaD) and pre-dementia stages, namely cognitive impairment no dementia (CIND), both of which fall under the spectrum of vascular cognitive impairment (VCI), has yet to be examined. Its correlations with inflammatory cytokines in cognitive impairment also await investigation. 80 subjects with no cognitive impairment (NCI), 160 with CIND and 144 with dementia were included in a cross-sectional study on a Singapore-based memory clinic cohort. All subjects underwent comprehensive clinical, neuropsychological and brain neuroimaging assessments, together with clinical diagnoses based on established criteria. Blood samples were collected and OPN as well as inflammatory cytokines interleukin (IL)-6, IL-8 and tumor necrosis factor (TNF) were measured using immunoassays. Multivariate regression analyses showed significant associations between increased OPN and VCI groups, namely CIND with CeVD, AD with CeVD and VaD. Interestingly, higher OPN was also significantly associated with AD even in the absence of CeVD. We further showed that increased OPN significantly associated with neuroimaging markers of CeVD and neurodegeneration, including cortical infarcts, lacunes, white matter hyperintensities and brain atrophy. OPN also correlated with elevated levels of IL-6, IL-8 and TNF. Our findings suggest that OPN may play a role in both VCI and neurodegenerative dementias. Further longitudinal analyses are needed to assess the prognostic utility of OPN in disease prediction and monitoring.
Source Title: SCIENTIFIC REPORTS
URI: https://scholarbank.nus.edu.sg/handle/10635/188280
ISSN: 20452322
DOI: 10.1038/s41598-021-83601-6
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
71 Chai Osteopontin MACC SREP 2021.pdf1.58 MBAdobe PDF

OPEN

PublishedView/Download

SCOPUSTM   
Citations

7
checked on May 20, 2022

Page view(s)

112
checked on May 12, 2022

Download(s)

1
checked on May 12, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.